VITIELLO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 917
AS - Asia 323
EU - Europa 161
SA - Sud America 88
AF - Africa 9
Totale 1.498
Nazione #
US - Stati Uniti d'America 896
SG - Singapore 158
BR - Brasile 74
CN - Cina 68
IT - Italia 58
VN - Vietnam 36
DE - Germania 30
HK - Hong Kong 26
GB - Regno Unito 19
CA - Canada 13
FR - Francia 9
JP - Giappone 9
PL - Polonia 9
AR - Argentina 8
IN - India 8
MX - Messico 7
BD - Bangladesh 6
NL - Olanda 6
RU - Federazione Russa 6
SE - Svezia 6
LT - Lituania 4
ZA - Sudafrica 4
AT - Austria 3
ES - Italia 3
FI - Finlandia 3
ID - Indonesia 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
IQ - Iraq 2
TR - Turchia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CO - Colombia 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
MA - Marocco 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 1.498
Città #
Dallas 728
Singapore 97
Ashburn 38
Hong Kong 26
Beijing 25
Los Angeles 17
Munich 17
New York 15
Ho Chi Minh City 14
São Paulo 12
Montreal 9
Hanoi 8
Hefei 8
Rome 8
Tokyo 8
Milan 7
Orem 7
Poplar 7
Warsaw 7
Bacoli 6
Frankfurt am Main 6
London 6
Manchester 6
Stockholm 6
Brooklyn 5
Cesano Boscone 5
Phoenix 5
Chennai 4
Chicago 4
Monza 4
Santa Clara 4
Atlanta 3
Boardman 3
Boston 3
Denver 3
Johannesburg 3
Mexico City 3
Moscow 3
Mumbai 3
Naples 3
Porto Alegre 3
Querétaro 3
Toronto 3
Belo Horizonte 2
Biên Hòa 2
Brussels 2
Cleveland 2
Da Nang 2
Duque de Caxias 2
Formosa 2
Guarulhos 2
Helena 2
Helsinki 2
Houston 2
Nuremberg 2
Pelotas 2
Pescara 2
Santa Fe 2
Shanghai 2
Trieste 2
Wroclaw 2
Agadir 1
Alexandria 1
Almirante Tamandaré 1
Alto Paraguai 1
Amstelveen 1
Amsterdam 1
Ankara 1
Annapolis 1
Antakya 1
Avaré 1
Barcelona 1
Bari 1
Belford Roxo 1
Belgrade 1
Brasília 1
Brazzaville 1
Buenos Aires 1
Cairo 1
Calgary 1
Campinas 1
Can Tho 1
Canoas 1
Cape Town 1
Carbonita 1
Cascavel 1
Caxias do Sul 1
Coimbatore 1
Colombo 1
Concord 1
Contagem 1
Danlí 1
Dhaka 1
Divinópolis 1
Erbil 1
Esteio 1
Falkenstein 1
Fortaleza 1
Guangzhou 1
Guanhães 1
Totale 1.230
Nome #
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab 387
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study 371
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 79
Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents 78
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 72
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions 51
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 49
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study 46
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab 43
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 42
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study 42
Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications 41
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma 40
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 39
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma 39
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 35
Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting 32
Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes 29
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment 15
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy 14
null 7
Totale 1.551
Categoria #
all - tutte 3.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 1 6 5
2024/2025117 6 0 0 3 8 10 11 16 5 5 10 43
2025/20261.422 114 390 489 231 176 22 0 0 0 0 0 0
Totale 1.551